INSM
Price
$71.96
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
2 days until earnings call
THAR
Price
$1.98
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
Ad is loading...

INSM vs THAR

Header iconINSM vs THAR Comparison
Open Charts INSM vs THARBanner chart's image
Insmed
Price$71.96
Change-$0.00 (-0.00%)
Volume$1.28M
CapitalizationN/A
Tharimmune
Price$1.98
Change-$0.00 (-0.00%)
Volume$41.28K
CapitalizationN/A
View a ticker or compare two or three
INSM vs THAR Comparison Chart
Loading...
INSM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
INSM vs. THAR commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSM is a StrongBuy and THAR is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (INSM: $71.96 vs. THAR: $1.98)
Brand notoriety: INSM and THAR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INSM: 85% vs. THAR: 109%
Market capitalization -- INSM: $12.46B vs. THAR: $2.85M
INSM [@Biotechnology] is valued at $12.46B. THAR’s [@Biotechnology] market capitalization is $2.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INSM’s FA Score shows that 1 FA rating(s) are green whileTHAR’s FA Score has 1 green FA rating(s).

  • INSM’s FA Score: 1 green, 4 red.
  • THAR’s FA Score: 1 green, 4 red.
According to our system of comparison, INSM is a better buy in the long-term than THAR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INSM’s TA Score shows that 2 TA indicator(s) are bullish while THAR’s TA Score has 5 bullish TA indicator(s).

  • INSM’s TA Score: 2 bullish, 7 bearish.
  • THAR’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, THAR is a better buy in the short-term than INSM.

Price Growth

INSM (@Biotechnology) experienced а -0.44% price change this week, while THAR (@Biotechnology) price change was -7.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

INSM is expected to report earnings on Feb 20, 2025.

THAR is expected to report earnings on Feb 28, 2024.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSM($12.5B) has a higher market cap than THAR($2.85M). INSM YTD gains are higher at: 132.204 vs. THAR (-74.067). THAR has higher annual earnings (EBITDA): -8.86M vs. INSM (-709.62M). INSM has more cash in the bank: 1.25B vs. THAR (7.9M). THAR has less debt than INSM: THAR (560K) vs INSM (1.22B). INSM has higher revenues than THAR: INSM (329M) vs THAR (0).
INSMTHARINSM / THAR
Capitalization12.5B2.85M438,750%
EBITDA-709.62M-8.86M8,008%
Gain YTD132.204-74.067-178%
P/E RatioN/A0.12-
Revenue329M0-
Total Cash1.25B7.9M15,793%
Total Debt1.22B560K217,321%
FUNDAMENTALS RATINGS
INSM: Fundamental Ratings
INSM
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
14
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INSMTHAR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
73%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
73%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
INSM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

INSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with THAR. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
+1.41%
THAR - INSM
74%
Closely correlated
+1.54%
CALT - INSM
69%
Closely correlated
N/A
AGIO - INSM
44%
Loosely correlated
+2.20%
SRPT - INSM
44%
Loosely correlated
-0.67%
VERA - INSM
41%
Loosely correlated
+15.21%
More

THAR and

Correlation & Price change

A.I.dvisor indicates that over the last year, THAR has been closely correlated with INSM. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if THAR jumps, then INSM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THAR
1D Price
Change %
THAR100%
+1.54%
INSM - THAR
74%
Closely correlated
+1.41%
CALT - THAR
57%
Loosely correlated
N/A
CMND - THAR
48%
Loosely correlated
-2.74%
SNGX - THAR
46%
Loosely correlated
+2.06%
SLRN - THAR
39%
Loosely correlated
+5.19%
More